NasdaqGS - Nasdaq Real Time Price USD
Standard BioTools Inc. (LAB)
1.0700
-0.0450
(-4.04%)
At close: May 9 at 4:00:00 PM EDT
1.0700
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.04 | -0.04 | -0.14 | -0.09 |
| Low Estimate | -0.04 | -0.04 | -0.14 | -0.11 |
| High Estimate | -0.04 | -0.04 | -0.14 | -0.07 |
| Year Ago EPS | -0.08 | -0.03 | -0.37 | -0.14 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 39.83M | 40.87M | 169.13M | 189.73M |
| Low Estimate | 37.2M | 38M | 165M | 186.4M |
| High Estimate | 41.7M | 43.4M | 171.4M | 195M |
| Year Ago Sales | 37.2M | 44.97M | 174.43M | 169.13M |
| Sales Growth (year/est) | 7.06% | -9.12% | -3.04% | 12.18% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.07 | -0.08 | -0.03 | -0.04 |
| EPS Actual | -0.08 | -0.03 | -0.05 | -0.05 |
| Difference | -0.01 | 0.04 | -0.02 | -0.01 |
| Surprise % | -7.60% | 53.87% | -64.67% | -19.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.04 | -0.04 | -0.14 | -0.09 |
| 7 Days Ago | -0.05 | -0.04 | -0.16 | -0.09 |
| 30 Days Ago | -0.05 | -0.04 | -0.16 | -0.09 |
| 60 Days Ago | -0.05 | -0.04 | -0.16 | -0.09 |
| 90 Days Ago | -0.03 | -0.05 | -0.16 | 0.03 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LAB | 49.30% | -15.61% | 61.98% | 35.71% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Downgrade | Keybanc: Overweight to Sector Weight | 2/27/2025 |
| Maintains | TD Cowen: Buy to Buy | 10/31/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/1/2024 |
| Initiated | TD Cowen: Buy | 4/16/2024 |
| Initiated | Jefferies: Buy | 4/4/2024 |
| Initiated | Keybanc: Overweight | 7/12/2023 |
Related Tickers
CTKB Cytek Biosciences, Inc.
2.9250
-22.82%
MXCT MaxCyte, Inc.
2.3550
-3.09%
QTRX Quanterix Corporation
5.28
-4.17%
RPID Rapid Micro Biosystems, Inc.
3.0800
+25.71%
BRKR Bruker Corporation
37.52
-7.38%
OFIX Orthofix Medical Inc.
12.11
-1.62%
PACB Pacific Biosciences of California, Inc.
1.1200
-6.67%
SERA Sera Prognostics, Inc.
2.2200
+4.72%
INGN Inogen, Inc.
6.24
-1.73%
STIM Neuronetics, Inc.
4.4300
-4.73%